Summary of findings: Sodium butyrate vs placebo
Acute and late GI toxicity (grade 2+) · Men undergoing RT for prostate cancer
Summary of findings: Sodium butyrate showed no clear difference in acute and late GI toxicity (grade 2+) compared with placebo (moderate certainty).
1 finding from 1 review
- Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes onlyRR 0.91 [0.41, 1.98]1 study · 79 participantsModerate